Robert C. Goeltz II
Chief Financial Officer · 2 filings · Latest: May 11, 2026
Arcus Biosciences, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RCUS | Robert C. Goeltz II | Chief Financial Officer | May 11, 2026 | Sale | $25.63 | 7,763 | $199.0K | 84,161 | |
RCUS | Robert C. Goeltz II | — | May 11, 2026 | Proposed Sale | $25.63 | 7,763 | $199.0K | — | |
RCUS | Robert C. Goeltz II | — | Dec 31, 2025 | Proposed Sale | $23.38 | 6,552 | $153.2K | — | |
RCUS | Robert C. Goeltz, II | — | Dec 16, 2025 | Proposed Sale | $21.90 | 14,000 | $306.6K | — | |
RCUS | Robert C. Goeltz II | — | Nov 26, 2025 | Proposed Sale | $25.00 | 5,000 | $125.0K | — | |
RCUS | Robert C. Goeltz II | — | Oct 28, 2025 | Proposed Sale | $20.00 | 5,000 | $100.0K | — | Oct 28 11:02 PM 144/A |
RCUS | Robert C. Goeltz II | — | Oct 28, 2025 | Proposed Sale | $20.00 | 5,000 | $100.0K | — | |
RCUS | Goeltz II Robert C. | — | Dec 31, 2024 | Proposed Sale | $15.00 | 3,594 | $53.9K | — |